16
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T8719 |
SC99
|
Apoptosis; JAK; STAT | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
SC99 是一种口服有效选择性STAT3抑制剂,靶向 JAK2-STAT3 途径,抑制血小板活化和聚集,有抗骨髓瘤和抗血栓活性。它结合在 JAK2 的 ATP 结合袋中,抑制 JAK2 和 STAT3 的磷酸化。 | |||
T25364L |
Efegatran sulfate
LY294468 sulfate,GYKI-14766 sulfate,LY 294468 sulfate,LY-294468 sulfate |
Thrombin | Proteases/Proteasome |
Efegatran sulfate (LY294468 sulfate) 是一种有效的凝血酶抑制剂,可用于治疗血栓类疾病。 | |||
T68092 |
Letaxaban
TAK-442 |
Factor Xa | Metabolism |
Letaxaban (TAK-442) 是一种口服活性的四氢嘧啶-2(1H)- 1衍生物和具有抗凝血活性的凝血因子Xa(激活因子X)抑制剂。Letaxaban 不影响出血时间。Letaxaban 已被用于研究静脉血栓栓塞和急性冠状动脉综合征的治疗和预防的试验。 | |||
T40802 |
Poloxamer 188
|
||
Poloxamer 188, a nonionic linear copolymer possessing surfactant properties, demonstrates anti-thrombotic, anti-inflammatory, and cytoprotective activities across different tissue injury models. | |||
T11659 |
Inogatran
伊诺加群,H-314-27 |
Others | Others |
Inogatran is a synthetic thrombin inhibitor, developed for the possible treatment and prophylaxis of venous and arterial thrombotic diseases. | |||
T78666 |
Egaptivon pegol
ARC 1779 |
Integrin | Cytoskeletal Signaling |
Egaptivon pegol (ARC1779)为一种核酸适配体,能够阻断von Willebrand Factor (VWF)与血小板GPIb受体的结合,从而展现其抗血栓功能。 | |||
T62949 | (1R,3S)-THCCA-Asn | ||
(1R,3S)-THCCA-Asn (4j) 是一种凝血酶 (thrombin) 的选择性抑制剂 (IC50: 0.07-0.14 μM),具有抗血栓形成作用。 | |||
T70106 |
F-050
|
||
F-050 is a biochemical that has been shown to inhibit platelet aggregation induced by CaCl2, arachidonic acid, collagen, adenosine diphosphate (ADP) and thrombin in guinea pigs, rabbits and rats in vitro. F-050 may be useful in the treatment of thrombotic diseases. | |||
T71429 |
O-Demethyl apixaban sulfate
|
||
O-Demethyl apixaban sulfate is a metabolite of Apixaban, a potent and highly selective factor Xa inhibitor. Apixaban is currently under development for treatment of arterial and venous thrombotic diseases. | |||
T64257 | FXIa-IN-8 | ||
FXIa-IN-8 是一种有效的、选择性的 FXIa 抑制剂 (IC50: 14.2 nM)。FXIa-IN-8 表现出抗血栓形成效果,而且不会提高出血风险及明显的毒性 sup>[1]。 | |||
T75689 |
Mumefural
|
||
Mumefural,Prunus mumeSieb 加工果实中的一种生物活性成分,具有抑制血小板聚集、显示抗血栓作用及改善认知障碍的功能。 | |||
T62507 | Protease-Activated Receptor-1 antagonist 1 | ||
Protease-Activated Receptor-1 antagonist 1 (Compound 13) 是一种蛋白酶激活受体 1 (PAR-1) 拮抗剂,通过 FLIPR 技术得到的 IC50 为 3 nM。Protease-Activated Receptor-1 antagonist 1 能够用于研究血栓性心血管、心肌梗塞和外周动脉疾病。 | |||
T71532 |
Fondaparinux free base
|
||
Fondaparinux Free Base is a synthetic pentasaccharide that mediates the interaction of HEPARIN with ANTITHROMBINS and inhibits FACTOR Xa; it is used for prevention of VENOUS THROMBOEMBOLISM after surgery. Fondaparinux is a clinically approved anticoagulant pentasaccharide for the treatment of thrombotic diseases, displays better efficacy and biosafety than other heparin-based anticoagulant drugs. | |||
T78283 |
Caplacizumab
ALX-0081,ALX-0681 |
||
Caplacizumab (ALX-0681)为人源化抗血管性血友病因子(vWF)纳米抗体,具有抑制vWF介导的血小板粘附作用,可阻止微血栓进一步形成。该化合物在血栓性血小板减少性紫癜(TTP)研究中应用。 | |||
T75408 | Batroxobin | ||
Batroxobin (DF-521),一种从Bothrops atrox moojeni获得的蛇毒,能促进血栓溶解,防止血栓复发并具有神经保护作用,显示出在脑静脉血栓性疾病研究中的潜力。 | |||
T20765 |
Atorvastatin
阿托伐他汀,阿伐他汀 |
HMG-CoA Reductase; Autophagy | Autophagy; Metabolism |
Atorvastatin 是一种具有口服活性的 HMG-CoA 还原酶抑制剂,通过激活肝细胞色素p450加快代谢,具有有效降低血脂的能力。Atorvastatin 以 IC50 值分别为 0.39 μM 和 2.39 μM 来抑制人 SV-SMC 细胞的增殖和侵袭。Atorvastatin 与氯吡格雷同时服用两种可能会导致患者血栓事件增加。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3P2904 |
α-Linolenic acid
Alpha-Linolenic Acid,Linolenic acid,α-亚麻酸 |
Akt; PI3K | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
α-Linolenic acid (Alpha-Linolenic Acid) 是一种必需脂肪酸,人体无法合成,从种子油中分离得到。它可调节 PI3K/Akt 信号传导,影响血栓形成过程。它具有抗心律失常的特性,并且与心血管疾病和癌症等有关。 | |||
T2S1749 |
Protogracillin
原纤细薯蓣皂甙 |
Others | Others |
Protogracillin 是一种甾体皂苷,分离自Dioscorea zingiberensisWright (DZW) 中。从 DZW 根状茎中获得的甾体皂苷具有抗血栓作用,同时由降低心血管疾病风险的潜力。 | |||
T3809 |
Liriope muscari baily saponins C
|
Others | Others |
Liriope muscari baily saponins C 是一种L. muscari (Decne.) Baily 的主要活性成分。它已被作为肿瘤转移候选药物进行研究。它具有很强的抗炎、免疫药理和心脏保护作用。 | |||
TN1312 |
6-Hydroxykaempferol 3-O-β-D-glucoside
6-Hydroxykaempferol 3-O-beta-D-glucoside,6-羟基山柰酚-3-O-Β-D-葡萄糖苷 |
Others | Others |
6-Hydroxykaempferol 3-O-beta-D-glucoside has anti-thrombotic,and antioxidative activities. | |||
T3839 |
Cycloolivil
Isoolivil,环橄榄树脂素 |
Free radical scavengers; Others; Platelet aggregation | Others; oxidation-reduction |
Cycloolivil (Isoolivil) 是一种天然多酚化合物,在橄榄树中具有显着的自由基清除活性。 Cycloolivil 具有抗氧化活性,它可以预防与血小板过度聚集相关的血栓并发症,是开发抗聚集治疗策略的基础。 | |||
TN1550 |
Danshenxinkun A
丹参新醌甲,丹参新醌A |
Others | Others |
Danshenxinkun A, Danshenxinkun B and Neocryptotanshinone may intervene thrombotic diseases by adjusting the targets mainly involved in pathways of endocrine system, signal transduction, signaling molecules and interaction, cell motility, environmental ada | |||
TN2106 |
Protodeltonin
原三角叶皂苷 |
BCL; PARP; Caspase | Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair; Proteases/Proteasome |
Protodeltonin may have anti-thrombotic activity by both improving the anticoagulation activity and inhibiting platelet aggregation action. Protodeltonin can inhibit the proliferation of a panel of established human and murine cancer cell lines in vitro. |